Community Based Treatment for (ComBaT) Glaucoma

University of Michigan logo

University of Michigan

Status

Not yet enrolling

Conditions

Glaucoma

Treatments

Behavioral: ComBaT Glaucoma

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06124521
K23MD016430-03 (U.S. NIH Grant/Contract)
HUM00207876

Details and patient eligibility

About

The purpose of this research is to evaluate if intervention and education can change the behavior of someone's willingness to see an eye care provider to prevent blindness and glaucoma. The researchers are investigating if adding additional resources improves participant access to care.

Full description

Outcome measures related to acceptability and feasibility are exploratory. They will not be registered or results reported.

Enrollment

60 estimated patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Black or African American
  • Participated in the screening examination portion of the study

Exclusion criteria

  • Current eye pain (> 8 out of 10)
  • Sudden decrease in vision (within 1 week)
  • Double vision that doesn't stop when you blink and stops no matter what eye you cover (not blurred, but seeing 2 objects)
  • Pregnant women
  • Prisoners
  • Cognitive impairment- unable to give an ocular and social history
  • Moving outside of Michigan or driving distance to the church within 6 months

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

60 participants in 1 patient group

Eye concern
Experimental group
Description:
Those with a diagnosis of glaucoma or glaucoma suspect (or other concerning eye disease, such as diabetic retinopathy or macular degeneration) will be invited to participate in the ComBaT Glaucoma.
Treatment:
Behavioral: ComBaT Glaucoma

Trial contacts and locations

1

Loading...

Central trial contact

Alexis Kendricks

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems